Device Device

Vivally

Payments companies reported to CMS as associated with Vivally. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$3,983associated payments (2023-2025)
108clinicians with associated payments
1company reporting

By year

2024 $3,983

Payments reported as associated with Vivally, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Urology $1,089
Physician Assistant $727
Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) $542
Urogynecology and Reconstructive Pelvic Surgery (Urology) $353
Family $192
Nurse Practitioner $188

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Vivally

These are the largest totals companies reported as associated with Vivally. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Michael Kennelly Charlotte, NC Urology $175.55
Eric Rovner Charleston, SC Urogynecology and Reconstructive Pelvic Surgery (Urology) $175.54
Colin Goudelocke New Orleans, LA Urology $175.54
Carol Bretschneider Chicago, IL Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) $168.95
Costas Apostolis Strongsville, OH Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) $168.79
Amanda White Arlington, TX Physician Assistant $136.32
Jason Kim Stony Brook, NY Urogynecology and Reconstructive Pelvic Surgery (Urology) $126.81
Jennifer Vandenberg Ft Worth, TX Acute Care (Nurse Practitioner) $117.50
William Houston Arlington, TX Physician Assistant $117.50
Patricia Magness Fort Worth, TX Gerontology (Nurse Practitioner) $117.50

Prescribed Vivally?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.